HSIC Henry Schein Inc

XNAS 86.00 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

HSIC $86.00 —
Key stats
$86.00
52-Week Range
$62.15 – $92.18
YTD
+11.95%
IV Rank (30D)
47.79
Straddle Price
$6.18
P/C Vol Ratio
0.41
Market Cap
$9.5B
Open
$84.81
Day Range
$84.81 – $86.26
Volume
2,075,089
Prev Close
$85.01
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.12%
Beta vs SPY0.71
Cost of Equity (CAPM)8.66% (VRP-adj)
WACC8.03%
Volatility Risk Premium+42.8pp (IV − HV30)
Effective Tax Rate23.9%
Rev. Growth (YoY, DCF input)+3.6%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.04 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.7B
Return on Equity (TTM)12.8%
Book / Price37.5% — banking bias active (P/B is primary)
Gross Margin (TTM)31.3%
FCF Margin (TTM)4.8%
Debt / Equity0.60
Quality Score0/6 — cyclical/struggling (5y DCF)
Market-Implied Growth+3.0% (reverse-DCF on current price)
SMA 50$87.05 (Market Anchor value)
SMA 20 / Bollinger Mid$85.02
Bollinger Width / SMA205.0% (drives anchor stability)
Net Debt$2.1B
Market Cap$10B
Peers used for multiples: AME, AMZN, CLH, DGX, FIX, ICE, PRMB, WMB
60-Day Conviction
70%
20-Day Fair Value
≈ by Nov 23, 2026
$87.84
α +2.1% rank 33%
conviction
92%
40-Day Fair Value
≈ by Dec 22, 2026
$88.69
α +3.1% rank 32%
conviction
87%
60-Day Fair Value
≈ by Jan 20, 2027
$87.88
α +2.2% rank 32%
conviction
70%
MethodImplied PriceWeightDetail
DCF $88.82 21%
DDM (Gordon) n/a 0%
Peer P/E $103.05 6% median 29.0× · 7 peers
Peer EV/EBITDA $146.82 6% median 17.1× · 7 peers
Peer P/B $165.52 6% median 5.1× · 7 peers
Peer P/S $522.74 6% median 4.4× · 7 peers
Market Anchor (SMA50) $87.05 41% stability 100% (BB-width)
Options Expected (B-L 30d) $88.63 13% 13 strikes · skew +1.32
As of 2026-10-23 · updated
About
Industry (SIC)
WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES (5047) · industry map
Exchange
XNAS
Market Cap
$9.5B
Employees
25,000
List Date
1995-11-03
CIK
0001000228
Next Earnings
2026-11-03 (Pre-Market)
EPS Forecast
$1.34 (8 est.)
Headquarters
Melville, NY
Homepage
https://www.henryschein.com

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical serv…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan-0.96%-2.75%8.23%-0.95%16.70%-1.74%3.09%
Feb-8.32%13.73%-10.05%0.98%-9.30%9.40%-0.59%
Mar7.27%1.02%4.87%-1.77%-3.28%-9.43%-0.22%
Apr5.58%-9.22%-1.25%-6.68%-5.94%2.12%-2.56%
May2.74%6.45%-10.32%0.81%8.58%3.58%1.97%
Jun-2.47%-8.95%10.45%-8.01%5.02%9.32%0.89%
Jul6.14%2.23%-0.91%10.49%-9.17%1.40%1.70%
Aug-6.94%-6.35%-2.89%-3.06%2.35%3.80%-2.18%
Sep-0.65%-9.52%-2.75%3.46%-2.95%-5.14%-2.93%
Oct-2.78%0.57%-11.35%-2.38%-3.66%1.26%*-3.06%
Nov-7.29%12.80%4.15%9.49%15.36%--6.90%
Dec10.22%-3.71%8.87%-9.54%3.38%--1.84%
Total0.46%-6.98%-6.06%-8.90%13.82%13.82%1.03%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $85.02
SMA 50: $87.05
SMA 200: $80.83
Current: $86.00
EMA 12: $85.23
EMA 26: $85.57
MACD: -0.3399 | Signal: 0.1974
BEARISH
ADX (14): 19.39
RANGE
+DI: 18.27
−DI: 22.53

Momentum Oscillators

RSI (14): 51.74
NEUTRAL
Stoch %K: 66.89
Stoch %D: 63.48
Williams %R: -24.32

Volume & Volatility

BB Upper: $86.83
BB Lower: $83.21
NEUTRAL
OBV: 49,419,323
Vol SMA 20: 1,271,587
Vol ROC: -22.45%
ATR: $1.96
True Range: $1.45
HV 20: 18.2%
HV 30: 20.6%
HV 60: 18.7%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-24T00:00:00 – 2026-10-22T00:00:00
AI Analysis

HSIC (Henry Schein Inc.) - Comprehensive Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL with Confidence Level: 6/10

Henry Schein presents a mixed technical and fundamental picture with conflicting signals that warrant cautious observation rather than directional conviction. While the options market and recent news sentiment are constructive, technical momentum has deteriorated significantly, and the stock is trading below its key moving averages. The company's defensive characteristics (beta 0.50) and institutional buying interest provide downside cushion, but the lack of positive technical confirmation limits upside enthusiasm.

Key Drivers:

  • Strong tailwinds from industry growth (clear aligners market projected at $99.44B by 2034, invisible orthodontics at $96.27B)
  • Record quarterly results and new $200M efficiency plan (positive capital allocation signal)
  • Bullish options positioning (0.17 put/call volume ratio, 82 calls vs 14 puts)

Primary Risks:

  • Bearish MACD divergence (-0.92) and deteriorating momentum indicators
  • Price trading below all major moving averages (SMA 20: $86.78, SMA 50: $87.71)
  • Significant volume decline (volume ROC: -43.06%) suggesting weakening institutional interest
  • IV premium at 283.9% vs realized volatility indicates options pricing elevated risk

Investment Thesis: HSIC is a defensive healthcare play with exposure to high-growth secular trends in orthodontics and dental markets, supported by recent operational improvements. However, current technical weakness and volume deterioration suggest waiting for confirmation of reversal before establishing positions. The defensive beta (0.50) makes this suitable for portfolio stability rather than tactical gains.

Recent News Sentiment Impact: News is overwhelmingly positive (4 positive vs 1 negative headline in recent period), focusing on market growth projections and company operational success. However, these gains appear largely priced in given the stock's technical weakness, suggesting sentiment-to-price divergence.

Technical Analysis

Trend Direction

Short-term (1-4 weeks): BEARISH

  • Price: $84.93 is trading below SMA 20 ($86.78), SMA 50 ($87.71), and EMA 12 ($85.75)
  • ADX (14) at 18.42 indicates weak directional momentum (below 25 = weak trend)
  • Negative -DI dominance (23.55 vs +DI 14.67) shows sellers currently in control
  • MACD histogram deeply negative at -0.69 with bearish crossover structure

Medium-term (1-3 months): NEUTRAL/WEAKLY BEARISH

  • Price remains above SMA 200 ($80.23), maintaining longer-term uptrend structure
  • However, the pullback through the 50-day MA suggests loss of intermediate momentum
  • EMA 26 ($86.67) provides a near-term ceiling, and price is testing support near Bollinger Band lower threshold ($83.07)

Long-term (3-12 months): NEUTRAL

  • Trading well above the 200-day MA ($80.23) indicates underlying long-term strength intact
  • Sector tailwinds (clear aligner market growth) support structural bullishness
  • Pattern suggests consolidation rather than breakdown at this price level

Support/Resistance Levels

| Level | Type | Significance | Distance | |-------|------|-------------|----------| | $83.07 | Support | Bollinger Band Lower | -2.3% | | $80.23 | Support | SMA 200 / Major | -5.5% | | $84.93 | Current | Price | — | | $86.78 | Resistance | SMA 20 | +2.2% | | $87.71 | Resistance | SMA 50 | +3.3% | | $90.50 | Resistance | Bollinger Band Upper | +6.4% |

Critical Analysis: The support/resistance structure is compressed with relatively tight bands, indicating the stock is in a consolidation phase. The proximity of the lower Bollinger Band ($83.07) suggests oversold conditions may be emerging, creating a potential bounce opportunity. However, the lack of buying volume makes sustained support unlikely without external catalysts.

Momentum Signals

RSI (14): 42.67 — NEUTRAL / SLIGHTLY WEAK

  • Reading of 42.67 is solidly in neutral zone (30-70) but positioned in the lower half
  • Not yet at oversold (<30) but approaching the inflection point
  • Suggests room for further downside before mean-reversion bounce likely
  • Interpretation: Momentum waning but not yet exhausted; no immediate reversal signal

MACD: BEARISH DIVERGENCE

  • MACD line (-0.92) significantly below signal line (-0.23)
  • Histogram deeply negative (-0.69) and expanding downward
  • This indicates accelerating bearish momentum, not just flat sentiment
  • Signal Interpretation: This is the most concerning technical indicator; suggests momentum deterioration will likely continue near-term

Stochastic Oscillators: OVERSOLD TERRITORY

  • Stochastic %K: 15.58 (very oversold, <20)
  • Stochastic %D: 21.56 (also oversold)
  • Williams %R: -71.97 (extreme oversold)
  • Significance: These readings suggest short-term bounce potential, BUT require confirmation from other indicators (volume, MACD recovery)

Bollinger Bands: NEUTRAL / SQUEEZE SETTING

  • Width: 8.57 (moderate width, not extreme squeeze)
  • Price near lower band ($83.07) indicates oversold positioning
  • Band positioning suggests consolidation with potential mean reversion to $86.78 middle band
  • Setup: Classic oversold bounce setup IF volume confirms, but the bearish MACD divergence contradicts this interpretation

Volume Analysis

CRITICAL WEAKNESS - Volume Deterioration:

  • Volume Rate of Change: -43.06% — Dramatic decline from historical averages
  • Volume SMA 20: 1,135,003.60 shares/day (institutional baseline)
  • Current trading suggests volume well below this average
  • OBV at 49,503,246.51 (difficult to contextualize without trend, but flat/declining OBV common with pullbacks)

Interpretation: The -43% volume decline is highly significant and contradicts any bullish scenario. Low volume declines reduce the credibility of technical support levels and suggest:

  • Institutional investors have reduced exposure/are on sidelines
  • Retail selling pressure without offsetting institutional buying
  • Potential for sharper breakdown if negative catalyst emerges
  • Conversely, recovery on volume would be more credible if it occurs

Institutional Interest Signals: The sharp volume drop paired with positive news suggests institutional hesitation despite sector tailwinds. This is a red flag suggesting smart money may be waiting for lower entry points.

News & Sentiment Analysis

Recent Headlines Summary

| Date | Headline | Sentiment | Theme | |------|----------|-----------|-------| | 2026-02-10 | Clear Aligners Market to $99.44B by 2034 | POSITIVE | Market Growth | | 2026-02-05 | Invisible Orthodontics to $96.27B by 2034 (28.54% CAGR) | POSITIVE | Market Growth | | 2026-02-04 | US PPE Market Outlook | NEUTRAL | Broad Category | | 2026-01-28 | Bruxism Treatment Market to $1.13B by 2033 | POSITIVE | Market Growth | | 2025-12-29 | Fund Buying HSIC on Record Results + $200M Efficiency Plan | POSITIVE | Company Specific | | 2025-11-13 | Oklahoma Medical Lab Corruption Expose | NEGATIVE | Regulatory Risk |

Sentiment Assessment

Aggregate Sentiment: POSITIVE (70% positive, 15% neutral, 15% negative)

The news flow is predominantly constructive with four directly positive catalysts in the past ~10 weeks. The December news of record quarterly results combined with a $200M efficiency plan is particularly bullish, showing management commitment to shareholder returns and operational improvement. The multiple headlines about clear aligner and invisible orthodontics market expansion provide secular growth visibility—these are HSIC's core growth vectors.

However: The positive sentiment has NOT translated to technical strength (price down with volume declining), creating a critical sentiment-to-price divergence. This suggests:

  1. News may be market-consensus knowledge (already priced in)
  2. Institutional investors are selectively taking profits despite good news 3
Generated
News
All HSIC news →
Earnings History
17 of 23 under expected move
Avg Expected Move
6.67%
Avg Actual Move
4.35%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-02-17 Pre-Market 5.99% 8.09% 1.35x Exceeded
2021-05-04 Pre-Market 5.67% 7.92% 1.40x Exceeded
2021-08-03 Pre-Market 6.43% 1.06% 0.16x Within
2021-11-02 Pre-Market 8.10% 2.07% 0.26x Within
2022-02-15 Pre-Market 5.74% 7.98% 1.39x Exceeded
2022-05-03 Pre-Market 7.71% 2.03% 0.26x Within
2022-08-02 Pre-Market 6.95% 3.67% 0.53x Within
2022-11-01 Pre-Market 7.96% 4.79% 0.60x Within
2023-02-16 Pre-Market 1.90% 6.57% 3.46x Exceeded
2023-05-09 Pre-Market 5.64% 6.23% 1.10x Exceeded
2023-08-07 Pre-Market 5.07% 2.84% 0.56x Within
2023-11-13 Pre-Market 6.60% 5.35% 0.81x Within
2024-02-27 Pre-Market 7.09% 3.38% 0.48x Within
2024-05-07 Pre-Market 6.98% 3.90% 0.56x Within
2024-08-06 Pre-Market 8.23% 8.11% 0.99x Within
2024-11-05 Pre-Market 8.68% 4.62% 0.53x Within
2025-02-25 Pre-Market 8.79% 2.34% 0.27x Within
2025-05-05 Pre-Market 7.73% 1.96% 0.25x Within
2025-08-05 Pre-Market 7.14% 7.41% 1.04x Exceeded
2025-11-04 After-Close 6.98% 0.56% 0.08x Within
2026-02-24 Pre-Market 7.97% 3.45% 0.43x Within
2026-05-05 After-Close 4.24% 2.60% 0.61x Within
2026-08-04 Pre-Market 5.92% 3.01% 0.51x Within

Earnings calendar: this week’s reports with expected vs actual moves →

HSIC Options Activity & IV Rank

HSIC IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 30.6%
7-DTE IV: —
Expected Move: $6.18
7-DTE Move: $6.18
Days to Exp: 29 (2026-11-20)

Options Flow

Call Volume: 152
Put Volume: 63
P/C Volume: 0.414
BULLISH
Call OI: 4,313
Put OI: 147
P/C OI: 0.034
Total OI: 4,460

ATM Options Pricing

ATM Call: $3.83
ATM Put: $2.35
Call %: 4.4%
Put %: 2.7%

Chain Summary

Chain Volume: 462
Chain OI: 10,093
Last Updated: 10/22/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 81st percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
81%
vs own history
GEX tilt
+0.97
OI-weighted, today
Vanna tilt
+0.31
δ-sensitivity to IV
Charm tilt
+0.18
δ-decay vs time
Vanna tilt +0.31: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 14 ATM contracts, 6k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 22 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 22 · ATM 31.3% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)47.8MediumOct 22
Straddle Price (30 DTE)$6.18Oct 22
Beta Analysis

Risk Metrics

Beta: 0.4450
Alpha: 27.28%
Correlation: 0.2226
R-Squared: 5.0%
Stock Volatility: 25.5%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own HSIC
5 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$244.0M
0.14%
#146 of 6285+8703.0%13F
Bridgewater Associates Hedge fund
Ray Dalio
$4.9M
0.02%
#486 of 997+83.8%13F
Point72 Hedge fund
Steve Cohen
$3.1M
0.00%
#1140 of 1945-92.8%13F
Rockefeller Capital Management Family office
Rockefeller family
$415K
0.00%
#2183 of 47290.0%13F
Millennium Management Hedge fund
Izzy Englander
$321K
0.00%
#3329 of 3716-97.7%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

HSIC Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 118,301,433 (as of 2026-06-27)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

602 filers137,014,335 shares$11.32B value115.82% of float
# Filer Shares Value % of Total % of Float Period
1 Kohlberg Kravis Roberts & Co. L.P. 15,652,032 $1.31B 11.55% 13.23% 2026-06-30
2 Vanguard Group Inc Custodian 11,588,199 $875.84M 7.74% 9.80% 2025-12-31
3 FMR LLC Custodian 7,553,901 $630.90M 5.58% 6.39% 2026-06-30
4 BlackRock, Inc. Custodian 7,024,663 $586.70M 5.18% 5.94% 2026-06-30
5 Artisan Partners Limited Partnership 6,467,467 $540.16M 4.77% 5.47% 2026-06-30
6 Vanguard Capital Management LLC 6,346,669 $530.07M 4.68% 5.36% 2026-06-30
7 JPMorgan Chase & Co Custodian 4,342,929 $366.43M 3.24% 3.67% 2026-06-30
8 State Street Corp 4,305,276 $359.58M 3.18% 3.64% 2026-06-30
9 Vanguard Portfolio Management LLC 4,133,442 $345.23M 3.05% 3.49% 2026-06-30
10 American Century Companies, Inc. 3,457,175 $288.74M 2.55% 2.92% 2026-06-30
11 Dimensional Fund Advisors LP Custodian 3,394,242 $283.50M 2.51% 2.87% 2026-06-30
12 Southpoint Capital Advisors LP 3,300,000 $275.62M 2.44% 2.79% 2026-06-30
13 Invesco Ltd. Custodian 3,150,237 $263.11M 2.33% 2.66% 2026-06-30
14 Citadel Advisors LLC Custodian 2,921,103 $243.97M 2.16% 2.47% 2026-06-30
15 Geode Capital Management, LLC Custodian 2,729,030 $227.54M 2.01% 2.31% 2026-06-30
16 Palestra Capital Management LLC 2,446,691 $204.35M 1.81% 2.07% 2026-06-30
17 Bank of Montreal Custodian 2,115,510 $176.69M 1.56% 1.79% 2026-06-30
18 Morgan Stanley Custodian 2,100,819 $175.46M 1.55% 1.78% 2026-06-30
19 FIDUCIARY MANAGEMENT INC /WI/ 1,817,353 $151.79M 1.34% 1.54% 2026-06-30
20 Burgundy Asset Management Ltd. 2,170,871 $151.05M 1.33% 1.83% 2025-09-30
21 LYRICAL ASSET MANAGEMENT LP 1,467,351 $122.55M 1.08% 1.24% 2026-06-30
22 UBS Group AG Custodian 1,336,843 $111.65M 0.99% 1.13% 2026-06-30
23 Swedbank AB 1,310,822 $109.48M 0.97% 1.11% 2026-06-30
24 M.D. Sass, LLC 1,286,942 $107.49M 0.95% 1.09% 2026-06-30
25 SNYDER CAPITAL MANAGEMENT L P 1,285,225 $107.34M 0.95% 1.09% 2026-06-30
10 filers$65.71M notional
# Filer Notional Value % of Total Period
1 Jane Street Group, LLC Custodian $22.98M 34.97% 2026-06-30
2 Susquehanna International Group, LLP Custodian $14.87M 22.64% 2026-06-30
3 Ulysses Management LLC $12.53M 19.07% 2026-06-30
4 Walleye Trading LLC $4.87M 7.41% 2026-06-30
5 GROUP ONE TRADING LLC Custodian $4.25M 6.47% 2026-06-30
6 Citadel Advisors LLC Custodian $2.97M 4.52% 2026-06-30
7 Wolverine Trading, LLC Custodian $1.27M 1.93% 2025-09-30
8 IMC-Chicago, LLC Custodian $1.10M 1.68% 2026-06-30
9 Simplex Trading, LLC Custodian $701.57K 1.07% 2026-06-30
10 Walleye Capital LLC $167.04K 0.25% 2026-06-30
8 filers$23.32M notional
# Filer Notional Value % of Total Period
1 UBS Group AG Custodian $20.88M 89.54% 2026-06-30
2 Susquehanna International Group, LLP Custodian $1.10M 4.73% 2026-06-30
3 Citadel Advisors LLC Custodian $551.23K 2.36% 2026-06-30
4 Wolverine Trading, LLC Custodian $376.49K 1.61% 2025-09-30
5 IMC-Chicago, LLC Custodian $317.38K 1.36% 2026-06-30
6 GROUP ONE TRADING LLC Custodian $41.76K 0.18% 2026-06-30
7 Walleye Capital LLC $41.76K 0.18% 2026-06-30
8 Simplex Trading, LLC Custodian $8.35K 0.04% 2026-06-30

HSIC Insider Trading (Form 4)

Latest: 2026-09-09
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-09 Andrea Albertini CEO, Global Dist. & Tech. Mixed −4,587 $88.86 -$53.6K EDGAR
2026-06-15 William K Daniel Director Award (A) +2,215 — EDGAR
2026-05-26 Stanley M Bergman Gift (G) −50 — EDGAR
2026-05-22 Stanley M Bergman Director Gift (G) −50 — EDGAR
2026-05-21 Stanley M Bergman Director Gift (G) −1,040 — EDGAR
2026-05-12 William K Daniel Director Buy (P) +10,000 $69.19 $691.9K EDGAR
2026-03-20 Thomas C Popeck CEO, Henry Schein Products Sell (S) −1,355 $72.79 -$98.6K EDGAR
2026-03-17 Andrea Albertini CEO, Global Dist. & Tech. Tax (F) −1,401 $74.61 -$104.5K EDGAR
2026-03-17 Stanley M Bergman Director Mixed −450 $74.61 -$3.7K EDGAR
2026-03-17 Michael S Ettinger EVP & Chief Operating Officer Mixed −6,514 $74.61 -$314.4K EDGAR
2026-03-17 Mark E Mlotek EVP, Chief Strategic Officer Tax (F) −5,928 $74.61 -$442.3K EDGAR
2026-03-17 Thomas C Popeck CEO, Henry Schein Products Tax (F) −587 $74.61 -$43.8K EDGAR
2026-03-17 Christine Zayac Sheehy SVP, Chief Human Res. Officer Tax (F) −463 $74.61 -$34.5K EDGAR
2026-03-17 Ronald N. South SVP & Chief Financial Officer Tax (F) −5,216 $74.61 -$389.2K EDGAR
2026-03-16 Stanley M Bergman Director Gift (G) −970 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

HSIC Insider Holdings

24 insiders · @ $86.00
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Stanley M Bergman Director 263,133 $22.63M -$106.61M 97 2026-05-26
2 James P Breslawski President 200,227 $17.22M -$51.06M 51 2025-03-17
3 Andrea Albertini CEO, Global Dist. & Tech. 116,104 $9.98M $0 8 2026-09-09
4 Michael S Ettinger EVP & Chief Operating Officer 112,418 $9.67M -$9.43M 48 2026-03-17
5 Mark E Mlotek EVP, Chief Strategic Officer 102,458 $8.81M -$30.87M 67 2026-03-17
6 Frederick M. Lowery CEO 95,156 $8.18M $0 2 2026-03-10
7 Ronald N. South SVP & Chief Financial Officer 88,930 $7.65M $0 10 2026-03-17
8 Thomas C Popeck CEO, Henry Schein Products 86,182 $7.41M -$98.6K 7 2026-03-20
9 Bradford C Connett CEO, NA Distribution Group 62,688 $5.39M -$2.15M 13 2025-03-20
10 Bradley T Sheares Director 47,623 $4.10M -$999.9K 25 2026-03-09
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

HSIC Board & Officers

As of SEC filings through Sep 9, 2026

Directors 14

Officers 8

10% owners 21

Changes in the last 10 years (58)
May 26, 2026Stanley M Bergman reported in an SEC filing no longer being a director
May 21, 2026Kelly Ann Murphy became SVP & General Counsel
Mar 3, 2026Mark E Mlotek no longer listed as a director in SEC filings
Mar 2, 2026Frederick M. Lowery became a director
Mar 2, 2026Frederick M. Lowery became CEO
Dec 23, 2025The company announced the departure of Stanley M Bergman as Chairman, CEO in an SEC filing
Sep 5, 2025The company announced the departure of James P Breslawski from the board in an SEC filing
Aug 14, 2025KKR Hawaii Holdings L.P. became a 10% owner
May 23, 2025Carol Raphael reported in an SEC filing no longer being a director
May 22, 2025Christine Zayac Sheehy became SVP, Chief Human Res. Officer
May 16, 2025William K Daniel became a director
May 14, 2025MH Sub I, LLC became a 10% owner
May 14, 2025KKR North America XIII S.a r.l. became a 10% owner
May 14, 2025KKR North America XIII Holdings Ltd became a 10% owner
May 14, 2025KKR North America Fund XIII SCSp became a 10% owner
May 14, 2025KKR Management LLP became a 10% owner
May 14, 2025KKR Indigo Aggregator III GP LLC became a 10% owner
May 14, 2025KKR Hawaii Aggregator L.P. became a 10% owner
May 14, 2025KKR Hawaii Aggregator GP LLC became a 10% owner
May 14, 2025KKR Group Partnership L.P. became a 10% owner
Not reported recently (19)
  • Bradford C Connett · Last reported as CEO, NA Distribution Group in an SEC filing dated Mar 20, 2025
  • Walter Siegel · Last reported as Sr. VP & Chief Legal Officer in an SEC filing dated Mar 17, 2025
  • Lorelei McGlynn · Last reported as SVP, Chief Human Res. Officer in an SEC filing dated Sep 9, 2024
  • Steven Paladino · Last reported as a director in an SEC filing dated Mar 5, 2024
  • David B Brous Jr · Last reported as CEO, Strategic Business Group in an SEC filing dated Jun 13, 2023
  • Gerald A Benjamin · Last reported as EVP, Chief Admin. Officer in an SEC filing dated May 27, 2022
  • E Dianne Rekow · Last reported as a director in an SEC filing dated May 18, 2022
  • Paul Brons · Last reported as a director in an SEC filing dated Mar 5, 2021
  • Shira Goodman · Last reported as a director in an SEC filing dated Mar 5, 2021
  • David McKinley · Last reported as CCO&Pres. Corp. Com. Dev. Grp. in an SEC filing dated Dec 3, 2018
  • Donald J Kabat · Last reported as a director in an SEC filing dated Mar 8, 2018
  • Lawrence S Bacow · Last reported as a director in an SEC filing dated Mar 8, 2018
  • Karen Prange · Last reported as EVP&CEO Gl.AH.Med.Den.Sur.Grp in an SEC filing dated Mar 6, 2018
  • Paul Rose · Last reported as SVP, Global Supply Chain in an SEC filing dated Sep 7, 2017
  • Robert Minowitz · Last reported as Pres., Int'l Dental Group EMEA in an SEC filing dated May 16, 2017
  • Michael Racioppi · Last reported as SVP Chief Merchandising Offic. in an SEC filing dated Mar 21, 2017
  • Peter M. McCarthy · Last reported as Pres., Global Animal Health in an SEC filing dated Mar 15, 2017
  • James A. Harding · Last reported as SVP, Chief Technology Officer in an SEC filing dated Mar 9, 2017
  • Bridget A Ross · Last reported as President, Global Medical Grp in an SEC filing dated Mar 8, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

HSIC Proposed Insider Sales (Form 144)

Latest: 2026-08-14
Last 30d: 0 filings  ·  Last 90d: 1 filing · $3.2M notice value · 1 unique filer

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Stanley M. Bergman (1, $3.2M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-08-14 Stanley M. Bergman Former Affiliate 35,257 $3.18M 2026-08-14 J.P. Morgan Securities LLC — EDGAR
2026-06-30 HERRING JOSEPH L Former Director 28,791 $2.43M 2026-06-30 Fidelity Brokerage Services LLC — EDGAR
2026-06-16 Stanley M. Bergman Affiliate 16,933 $1.37M 2026-06-16 J.P. Morgan Securities LLC — EDGAR
2026-03-19 Popeck Thomas C Officer 1,355 $98.6K 2026-03-19 Fidelity Brokerage Services LLC — EDGAR
2026-03-10 KUEHN KURT P Director 2,844 $224.6K 2026-03-10 Fidelity Brokerage Services LLC — EDGAR
2026-03-05 LASKAWY PHILIP A Director 2,844 $228.5K 2026-03-05 Fidelity Brokerage Services LLC — EDGAR
2026-03-04 MLOTEK MARK E Officer 5,925 $478.7K 2026-03-04 Fidelity Brokerage Services LLC — EDGAR
2026-03-02 Stanley M. Bergman CEO, Chairman 43,812 $3.61M 2026-03-02 J.P. Morgan Securities LLC — EDGAR
2026-02-27 Stanley M. Bergman CEO, Chairman 10,785 $878.7K 2026-02-27 J.P. Morgan Securities LLC — EDGAR
2026-02-26 Stanley M. Bergman Officer, Director 43,046 $3.53M 2026-02-26 J.P. Morgan Securities LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-22
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-22 0001193125-26-235496 EDGAR
2026-05-05 0001000228-26-000021 EDGAR
2026-02-24 0001000228-26-000010 EDGAR
2026-01-12 0001193125-26-009725 EDGAR
2025-12-23 0001193125-25-329486 EDGAR
2025-12-23 0001193125-25-330853 EDGAR
2025-12-09 0001193125-25-311953 EDGAR
2025-11-04 0001000228-25-000063 EDGAR
2025-09-09 0001193125-25-199164 EDGAR
2025-08-05 0001000228-25-000042 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-24 0001000228-26-000013 EDGAR
2025-02-25 0001000228-25-000014 EDGAR
2024-02-28 0001000228-24-000011 EDGAR
2023-02-21 0001000228-23-000011 EDGAR
2022-02-15 0001000228-22-000016 EDGAR
2021-02-17 0001000228-21-000019 EDGAR
2020-02-20 0001000228-20-000018 EDGAR
2019-02-20 0001000228-19-000015 EDGAR
2018-02-21 0001000228-18-000012 EDGAR
2017-02-21 0001000228-17-000011 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-05 0001000228-26-000024 EDGAR
2025-11-04 0001000228-25-000066 EDGAR
2025-08-05 0001000228-25-000045 EDGAR
2025-05-05 0001000228-25-000025 EDGAR
2024-11-05 0001000228-24-000064 EDGAR
2024-08-06 0001000228-24-000054 EDGAR
2024-05-07 0001000228-24-000025 EDGAR
2023-11-28 0001000228-23-000052 EDGAR
2023-08-07 0001000228-23-000043 EDGAR
2023-05-09 0001000228-23-000026 EDGAR
ETF Holders
185 ETFs hold HSIC
25 shown · $1.64B total exposure · 0.02% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.01% $253.2M — 2026-09-30
2 VOO Vanguard S&P 500 ETF Vanguard 0.01% $211.2M — 2026-09-30
3 RSP Invesco S&P 500 Equal Weight ETF Invesco 0.19% $189.7M — 2026-10-21
4 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.10% $179.7M — 2026-09-30
5 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.18% $117.0M — 2026-09-30
6 IVV iShares Core S&P 500 ETF iShares (BlackRock) 0.01% $108.2M $878.4B 2026-10-21
7 SPY State Street® SPDR® S&P 500® ETF Trust SPDR (State Street) 0.01% $101.2M $820.7B 2026-10-21
8 DFAT Dimensional US Targeted Value ETF Dimensional 0.26% $78.2M — 2026-10-21
9 DFAS Dimensional US Small Cap ETF Dimensional 0.21% $70.5M — 2026-10-21
10 XLV State Street® Health Care Select Sector SPDR® ETF SPDR (State Street) 0.13% $59.5M $47.5B 2026-10-21
11 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.05% $40.2M — 2026-10-21
12 IWR iShares Russell Mid-Cap ETF iShares (BlackRock) 0.06% $35.1M $57.2B 2026-10-21
13 VHT Vanguard Health Care ETF Vanguard 0.11% $24.8M — 2026-09-30
14 SPYM State Street® SPDR® Portfolio S&P 500® ETF SPDR (State Street) 0.01% $22.4M $184.5B 2026-10-21
15 SCHM Schwab U.S. Mid-Cap ETF Nport 0.14% $20.7M — 2026-05-31
16 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.02% $18.7M $84.8B 2026-10-21
17 RSPH Invesco S&P 500 Equal Weight Health Care ETF Invesco 1.48% $14.2M — 2026-10-21
18 IVE iShares S&P 500 Value ETF iShares (BlackRock) 0.03% $13.6M $50.7B 2026-10-21
19 IWS iShares Russell Mid-Cap Value ETF iShares (BlackRock) 0.08% $12.7M $15.7B 2026-10-21
20 DCOR Dimensional US Core Equity 1 ETF Dimensional 0.03% $12.0M — 2026-10-21
21 RPV Invesco S&P 500 Pure Value ETF Invesco 0.62% $10.8M — 2026-10-21
22 FNDX Schwab Fundamental U.S. Large Company ETF Nport 0.04% $10.6M — 2026-05-31
23 FXH First Trust Health Care AlphaDEX® Fund First Trust 0.93% $10.6M $1.1B 2026-10-21
24 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.01% $10.5M $96.2B 2026-10-21
25 SPYV State Street® SPDR® Portfolio S&P 500® Value ETF SPDR (State Street) 0.03% $10.3M $38.4B 2026-10-21
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
25.07
TTM Diluted EPS
$3.43
TTM Revenue
$13.60B
TTM Net Income
$403.00M
TTM Op. Cash Flow
$782.00M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-27$3.46B$94.00M$0.82$242.00M
Q1 '262026-03-28$3.37B$107.00M$0.92$-97.00M
Q4 '252025-12-27$3.44B$101.00M$0.85$381.00M
Q3 '252025-09-27$3.34B$101.00M$0.84$256.00M
Q2 '252025-06-28$3.24B$86.00M$0.70$120.00M
Q1 '252025-03-29$3.17B$110.00M$0.88$37.00M
Q4 '242024-12-28$3.19B$94.00M$0.75$204.00M
Q3 '242024-09-28$3.17B$99.00M$0.78$131.00M
Q2 '242024-06-29$3.14B$104.00M$0.80$316.00M
Q1 '242024-03-30$3.17B$93.00M$0.72$197.00M
Q4 '232023-12-30$3.02B$18.00M$0.14$-50.00M
Q3 '232023-09-30$3.16B$137.00M$1.05$249.00M
Q2 2026 • period ending 2026-06-27 • filed 2026-08-04
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
25.07
P/B
2.67
P/S
0.75
EV/EBITDA
11.15
EV/Sales
0.91
ROE
10.6%
ROA
3.5%
Div Yield
0.00%
FCF Yield
7.69%
Debt/Equity
0.60
Current Ratio
—
Market Cap
$10.17B
as of 2026-10-22
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
8.32M
SI % of Float
8.74%
Days to Cover
6.61
Short Vol Ratio
35.3%
Free Float
95.18M
Float %
85.4%
Short interest 2026-09-30 • Short volume 2026-10-22 • Float 2026-09-22